46,XY,t(3;6)(p25;p25) de novo
Interpretation: Chromosome analysis of 21 cells cultured from amniotic fluid showed a male karyotype with a reciprocal translocation between chromosome 3 and chromosome 6.
The breakpoints were identified at 3p25 and 6p25.
The translocation appeared to be balanced.
To rule out familial inheritance of the translocation, parental blood samples were requested and analyzed.
Both parents exhibited normal karyotypes (MB-AF10-0487; PB-AF10-0487).
Therefore, the aberrations detected in the amniotic cells were de novo in origin.
It is challenging to provide an exact risk figure for phenotypic abnormalities resulting from a de novo reciprocal translocation, although an estimated risk of 6-7% has been suggested (Warburton, 1991, Am J Hum Genet 49:995-1013).
A detailed ultrasound examination of the fetus is highly recommended.
What psychological preparation should I have?
miaokw, 30~39 year old female. Ask Date: 2010/04/22
Dr. Jian Yingxiu reply Rare Disease
Hello: According to the text, the karyotype analysis did not show any significant increase or decrease in chromosomes.
However, since there are chromosomal variations, literature reports suggest there may be a 6-7% chance of associated abnormalities.
May I ask what the current gestational age is? I recommend that you promptly visit a genetic counseling center for further consultation and management.
Thank you.
Reply Date: 2010/04/22
More Info
Understanding de novo reciprocal translocations and their implications for fetal health can be a complex and emotionally charged topic. In your case, the analysis of amniotic fluid cells revealed a male karyotype with a balanced reciprocal translocation between chromosome 3 and chromosome 6, specifically at the breakpoints 3p25 and 6p25. Since both parents have normal karyotypes, this translocation is classified as de novo, meaning it occurred spontaneously in the fetus and was not inherited from either parent.
Balanced reciprocal translocations typically do not result in any phenotypic abnormalities in the individual carrying them. However, the risk of phenotypic abnormalities in offspring from a de novo translocation is not negligible. Research, including a study by Warburton in 1991, suggests that there is an estimated risk of around 6-7% for phenotypic abnormalities associated with de novo reciprocal translocations. This means that while the majority of individuals with such translocations may develop normally, there is a small but significant risk of developmental issues or congenital anomalies.
Given this information, it is crucial to approach the situation with a balanced perspective. Here are some key points to consider:
1. Understanding the Risk: While the risk of abnormalities is present, it is relatively low. Many individuals with balanced translocations lead healthy lives without any noticeable issues. The 6-7% risk indicates that the majority of cases will not result in significant health problems.
2. Importance of Monitoring: Detailed ultrasound examinations are highly recommended to monitor fetal development closely. These ultrasounds can help identify any potential issues early on, allowing for timely interventions if necessary.
3. Genetic Counseling: It may be beneficial to seek genetic counseling. A genetic counselor can provide you with more personalized information regarding the implications of the translocation, potential risks, and the options available for monitoring and managing the pregnancy.
4. Emotional Preparedness: It is natural to feel anxious or concerned about the health of your baby. Preparing yourself mentally and emotionally for the possibility of needing additional medical care or interventions can be helpful. Engaging in open discussions with your healthcare provider about your concerns can also provide reassurance and clarity.
5. Support Systems: Consider reaching out to support groups or communities where you can connect with other parents who have faced similar situations. Sharing experiences and advice can be comforting and informative.
6. Focus on Positivity: While it is essential to be aware of the risks, it is equally important to focus on the positive aspects of your pregnancy. Many families have healthy children despite similar genetic findings, and maintaining a hopeful outlook can be beneficial for both you and your baby.
In summary, while the presence of a de novo reciprocal translocation does carry some risk, the majority of cases do not lead to significant health issues. Regular monitoring through ultrasound and consultations with healthcare professionals will be key in managing the pregnancy. Remember to take care of your emotional well-being during this time, and do not hesitate to seek support when needed.
Similar Q&A
Understanding the Impact of Chromosomal Translocation on Rare Diseases
The amniocentesis diagnostic result shows 46,XY,t(4;8)(q25;p11.2), indicating a translocation between the long arm of chromosome 4 (q25) and the short arm of chromosome 8 (p11.2). Following the doctor's advice, an aCGH test has been conducted, but it is currently unclear whe...
Dr. Chen Ming reply Rare Disease
The incidence of balance displacement syndrome is actually one in five hundred, which is not uncommon. You have done what you needed to do; now we just wait for the results. May God bless you.[Read More] Understanding the Impact of Chromosomal Translocation on Rare Diseases
Understanding Chromosomal Abnormalities: Impacts of Spontaneous Mutations in Infants
Hello, my 20-week amniocentesis chromosomal analysis results are: arr[hg19]9p24.3p24.2(208,454_2,546,974)*1. The results indicate that this specimen is female, containing X chromosome sequences, but there is a deletion of a 2.34 Mb microdeletion in the short arm of chromosome 9 a...
Dr. Chen Ming reply Rare Disease
You can consult a renowned obstetrician in the area or call 04-7238595 extension 7244 to schedule an appointment.[Read More] Understanding Chromosomal Abnormalities: Impacts of Spontaneous Mutations in Infants
Understanding 3p26.3 Microdeletion: Implications for Fetal Health and Development
We are already far along in the pregnancy. Since discovering fetal heart abnormalities at 21 weeks, we underwent amniocentesis and genetic testing. The genetic testing revealed a deletion, and we went back for additional blood tests for comparison. By the time the blood test resu...
Dr. Wu Wanru reply Rare Disease
The information you are looking for pertains to symptoms caused by large deletions in the 3p region, rather than the VOUS (variants of uncertain significance) that you have currently tested positive for. However, these variants can be found in both normal and abnormal cases, and ...[Read More] Understanding 3p26.3 Microdeletion: Implications for Fetal Health and Development
Understanding 16p13.3 Microduplication: Implications for Fetal Health
Hello Doctor, I am a 30-year-old first-time mother who is 20 weeks pregnant. I have Graves' disease, which is well-controlled with medication. I have had intermittent mild microcytic anemia in the past, and my doctor has suspected either thalassemia or iron deficiency anemia...
Dr. Jian Yingxiu reply Rare Disease
Hello: Anticipating new life yet encountering such uncertainty can indeed be unsettling. It seems you have already gathered all the information, but due to incomplete penetrance, even if one parent has similar chromosomal variations, there is still a chance that the baby may expe...[Read More] Understanding 16p13.3 Microduplication: Implications for Fetal Health
Related FAQ
(Rare Disease)
Whole Exome Sequencing(Rare Disease)
Congenital Metabolic Disorders(Rare Disease)
Newborn Screening(Rare Disease)
G6Pd Deficiency(Rare Disease)
Osteogenesis Imperfecta(Rare Disease)
Kawasaki Disease(Rare Disease)
Tourette Syndrome(Rare Disease)
Ichthyosis(Rare Disease)
Height(Rare Disease)